SpectraCure AB (OSTO:SPEC) Buyback Yield %: -65.44 (As of Jul. 04, 2026)


What is SpectraCure AB Buyback Yield %?

SpectraCure AB OSTO:SPEC +10.38% Buyback Yield % is -65.44 as of Jul. 04, 2026. The stock has 1 warning sign investors should review. Among 347 Medical Devices & Instruments companies, SpectraCure AB ranks worse than 91.35% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

SpectraCure AB's current buyback yield was -65.44%.

SpectraCure AB Buyback Yield % Historical Data

* Premium members only.

The historical data trend for SpectraCure AB's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SpectraCure AB Buyback Yield % Chart

SpectraCure AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -85.79

SpectraCure AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -85.79 -32.09

OSTO:SPEC vs ABT, SYK, MDT: Buyback Yield % Comparison

For the Medical Devices subindustry, SpectraCure AB's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SpectraCure AB Buyback Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SpectraCure AB's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where SpectraCure AB's Buyback Yield % falls into.


SpectraCure AB Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

SpectraCure AB's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 54.756) / 63.8262744
=-85.79%

SpectraCure AB's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 16.094) / 50.1560037
=-32.09%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -65.44 mean?
SpectraCure AB (OSTO:SPEC) has a Buyback Yield % of -65.44 as of Jul. 04, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on SpectraCure AB and its competitors. According to the industry distribution chart, SpectraCure AB ranks #317 out of 347 companies in the Medical Devices & Instruments industry, placing it in the top 91.4%.
Is SpectraCure AB's Buyback Yield % too high?
SpectraCure AB's current Buyback Yield % is -65.44. Based on the distribution chart, SpectraCure AB ranks #317 out of 347 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does SpectraCure AB's Buyback Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, SpectraCure AB ranks #317 out of 347 companies for Buyback Yield %. This places SpectraCure AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on SpectraCure AB and its competitors. SpectraCure AB's current Buyback Yield % is -65.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SpectraCure AB stock overvalued right now?
SpectraCure AB (OSTO:SPEC) has a current Buyback Yield % of -65.44. The current Buyback Yield % is -65.44. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For SpectraCure AB (OSTO:SPEC), the current Buyback Yield % is -65.44 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SpectraCure AB Business Description

Address Magistratsvagen 10, Lund, SWE, 22643
SpectraCure AB develops treatment planning and laser light dose management for cancer treatment. The Company has developed its software IDOSE, and medical laser devices for the treatment.